INS and diabetic kidney disease: Characterizing the molecular and metabolic effects of IR on early kidney injury within the context of contemporary diabetes management (e.g., continuous glucose monitoring [CGM] and automated insulin delivery systems) and identifying modifiable risk factors could lead to more effective and targeted therapies to prevent development of progressive DKD.